Sam Strudwick joined IDDO in May 2017. As a Data Engineer, she is responsible for the development and testing of our data standards and processes. She also works on the management and transformation of the diverse data sets that are submitted to WWARN/IDDO and ensures the completeness and accuracy of the data in the WWARN/IDDO data repository.
Prior to joining IDDO, Sam worked as a Data Manager on stage four clinical trial data at the Melanoma Institute Australia. She has also worked as Bio-analytical Chemist developing qualitative analysis methods for novel anti-cancer drugs, and as Patent Administrator managing medical device patents in Sydney, Australia. She has a BSc (Hons) in Forensic Chemistry from the University of Technology, Sydney and a Diploma in Law from the Legal Profession Admission Board, New South Wales, Australia.
Professor Philippe Guérin is Director of the Infectious Diseases Data Observatory (IDDO). He was appointed Director of the WorldWide Antimalarial Research Network (WWARN) - the prototypic model for IDDO - in January 2009. Philippe has extensive experience working in the field for Médecins Sans Frontières and as a researcher for a Wellcome Trust Research Unit in many countries in Africa and Asia. Following three years as a Senior Advisor to the Department of Infectious Disease Epidemiology at the Norwegian Institute of Public Health, Philippe joined Épicentre in Paris - a World Health Organization (WHO) Collaborating Centre for Research in epidemiology and response to emerging diseases. Philippe served as Scientific Director for six years at Épicentre before moving to WWARN.
Prabin joined the WorldWide Antimalarial Research Network (WWARN) – the prototypic model to IDDO – as a statistician in September 2011. His work with WWARN included assessment of the relationship between weight-adjusted dose and parasitological outcomes for artemisinin combination therapies.
His doctoral thesis (2015–2018, Linacre College) explored different statistical approaches for handling parasitic recurrences when quantifying antimalarial blood stage efficacy in P. falciparum.
In his current role, Prabin's main focus is the quantification of risk of severe and serious adverse events following antileishmanial therapies. His interest lies in exploring methodological issues in design and analysis of antileishmanial clinical trials.
Research Theme: VL, Malaria, Non-Malarial Febrile Illness
Makoto is an infectious disease physician by training and a clinical epidemiologist. He joined WWARN/IDDO in 2015 as a DPhil student (2015-2019, at St Edmund Hall), under the supervision of Prof Philippe Guérin (IDDO Director) and Prof Rose McGready (SMRU, University of Oxford, Thailand).
Over the past several years, he has dedicated his work to studying the epidemiology of malaria in pregnancy, focusing particularly on the pharmacoepidemiology of antimalarials during pregnancy.
His research interests extend broadly to the epidemiology of clinical infectious diseases, with a particular focus on malaria and other tropical infectious diseases, as well as nosocomial bacterial infections and antimicrobial resistance (AMR).
He earned an MD from the University of Tokyo, as well as an MSc in Tropical Medicine and International Health and an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine. He is a certified epidemiologist and infectious disease specialist in Japan and a fellow of the Japanese Society of Internal Medicine.